These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33949201)

  • 21. Untargeted LC-MS metabolomics of bronchoalveolar lavage fluid differentiates acute respiratory distress syndrome from health.
    Evans CR; Karnovsky A; Kovach MA; Standiford TJ; Burant CF; Stringer KA
    J Proteome Res; 2014 Feb; 13(2):640-9. PubMed ID: 24289193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Host-Response Subphenotypes Offer Prognostic Enrichment in Patients With or at Risk for Acute Respiratory Distress Syndrome.
    Kitsios GD; Yang L; Manatakis DV; Nouraie M; Evankovich J; Bain W; Dunlap DG; Shah F; Barbash IJ; Rapport SF; Zhang Y; DeSensi RS; Weathington NM; Chen BB; Ray P; Mallampalli RK; Benos PV; Lee JS; Morris A; McVerry BJ
    Crit Care Med; 2019 Dec; 47(12):1724-1734. PubMed ID: 31634231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An NMR based panorama of the heterogeneous biology of acute respiratory distress syndrome (ARDS) from the standpoint of metabolic biomarkers.
    Viswan A; Singh C; Kayastha AM; Azim A; Sinha N
    NMR Biomed; 2020 Feb; 33(2):e4192. PubMed ID: 31733128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Explore potential plasma biomarkers of acute respiratory distress syndrome (ARDS) using GC-MS metabolomics analysis.
    Lin S; Yue X; Wu H; Han TL; Zhu J; Wang C; Lei M; Zhang M; Liu Q; Xu F
    Clin Biochem; 2019 Apr; 66():49-56. PubMed ID: 30779905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic profiling of serum samples by 1H nuclear magnetic resonance spectroscopy as a potential diagnostic approach for septic shock.
    Mickiewicz B; Duggan GE; Winston BW; Doig C; Kubes P; Vogel HJ;
    Crit Care Med; 2014 May; 42(5):1140-9. PubMed ID: 24368342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exhaled breath metabolomics as a noninvasive diagnostic tool for acute respiratory distress syndrome.
    Bos LD; Weda H; Wang Y; Knobel HH; Nijsen TM; Vink TJ; Zwinderman AH; Sterk PJ; Schultz MJ
    Eur Respir J; 2014 Jul; 44(1):188-97. PubMed ID: 24743964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolomic Profile of ARDS by Nuclear Magnetic Resonance Spectroscopy in Patients With H1N1 Influenza Virus Pneumonia.
    Izquierdo-Garcia JL; Nin N; Jimenez-Clemente J; Horcajada JP; Arenas-Miras MDM; Gea J; Esteban A; Ruiz-Cabello J; Lorente JA
    Shock; 2018 Nov; 50(5):504-510. PubMed ID: 29293175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Study on plasmatic metabolomics of Uygur patients with essential hypertension based on nuclear magnetic resonance technique.
    Zhong L; Zhang JP; Nuermaimaiti AG; Yunusi KX
    Eur Rev Med Pharmacol Sci; 2014; 18(23):3673-80. PubMed ID: 25535139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolomics and Cytokine Analysis for Identification of Severe Drug-Induced Liver Injury.
    Xie Z; Chen E; Ouyang X; Xu X; Ma S; Ji F; Wu D; Zhang S; Zhao Y; Li L
    J Proteome Res; 2019 Jun; 18(6):2514-2524. PubMed ID: 31002254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Six-month and 12-month patient outcomes based on inflammatory subphenotypes in sepsis-associated ARDS: secondary analysis of SAILS-ALTOS trial.
    Hashem MD; Hopkins RO; Colantuoni E; Dinglas VD; Sinha P; Aronson Friedman L; Morris PE; Jackson JC; Hough CL; Calfee CS; Needham DM
    Thorax; 2022 Jan; 77(1):22-30. PubMed ID: 34112703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The discovery of biological subphenotypes in ARDS: a novel approach to targeted medicine?
    Wildi K; Livingstone S; Palmieri C; LiBassi G; Suen J; Fraser J
    J Intensive Care; 2021 Jan; 9(1):14. PubMed ID: 33478589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exhaled breath profiling for diagnosing acute respiratory distress syndrome.
    Bos LD; Schultz MJ; Sterk PJ
    BMC Pulm Med; 2014 Apr; 14():72. PubMed ID: 24767549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discriminant biomarkers of acute respiratory distress syndrome associated to H1N1 influenza identified by metabolomics HPLC-QTOF-MS/MS platform.
    Ferrarini A; Righetti L; Martínez MP; Fernández-López M; Mastrangelo A; Horcajada JP; Betbesé A; Esteban A; Ordóñez J; Gea J; Cabello JR; Pellati F; Lorente JA; Nin N; Rupérez FJ
    Electrophoresis; 2017 Sep; 38(18):2341-2348. PubMed ID: 28714069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials.
    Calfee CS; Delucchi K; Parsons PE; Thompson BT; Ware LB; Matthay MA;
    Lancet Respir Med; 2014 Aug; 2(8):611-20. PubMed ID: 24853585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic signatures of acute respiratory distress syndrome: COVID versus non-COVID.
    Ji X; Ji HL
    Am J Physiol Lung Cell Mol Physiol; 2024 May; 326(5):L596-L603. PubMed ID: 38469648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal dysfunction reduces the diagnostic and prognostic value of serum CC16 for acute respiratory distress syndrome in intensive care patients.
    Lin J; Tao W; Wei J; Wu J; Zhang W; Ye J; Fu X; Zeng S; Dou Q; Wang L; Tian F
    BMC Pulm Med; 2020 Aug; 20(1):212. PubMed ID: 32787812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma metabolic profiling implicates dysregulated lipid metabolism and glycolytic shift in hyperinflammatory ARDS.
    Alipanah-Lechner N; Neyton L; Mick E; Willmore A; Leligdowicz A; Contrepois K; Jauregui A; Zhuo H; Hendrickson C; Gomez A; Sinha P; Kangelaris KN; Liu KD; Matthay MA; Rogers AJ; Calfee CS
    Am J Physiol Lung Cell Mol Physiol; 2023 Mar; 324(3):L297-L306. PubMed ID: 36648136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biomarker profiles of coagulopathy and alveolar epithelial injury in acute respiratory distress syndrome with idiopathic/immune-related disease or common direct risk factors.
    Koyama K; Katayama S; Tonai K; Shima J; Koinuma T; Nunomiya S
    Crit Care; 2019 Aug; 23(1):283. PubMed ID: 31426849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
    Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
    J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrative multi-omics analysis unravels the host response landscape and reveals a serum protein panel for early prognosis prediction for ARDS.
    Lin M; Xu F; Sun J; Song J; Shen Y; Lu S; Ding H; Lan L; Chen C; Ma W; Wu X; Song Z; Wang W
    Crit Care; 2024 Jul; 28(1):213. PubMed ID: 38956604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.